Blog Post

Lorne Attending (NCRI) Cancer Conference in Conjuction with Rockland Immunochemicals

14 July 2014

Lorne Attending (NCRI) Cancer Conference With Our Partners Rockland Immunochemicals

We will be exhibiting at the National Cancer Research Institute (NCRI) with our partners Rockland Immunochemicals this year. We will be joined by Rockland's CEO and President, James Fendrick, who will be available on the Lorne stand to answer any questions on Rockland's capabilities. The conference takes place from the 2-5 of November at the BT Convention Centre in Liverpool. During the conference Lorne and Rockland will be focusing on promoting the Rockland Immunochemicals range for which Lorne are the exclusive UK distributor. Rockland products are used in a wide variety of laboratory and research environments specialising in antibodies and assays. Rockland Immunochemicals are partnered with the National Cancer Institute’s Centre for Cancer Research in the USA. Rockland has released a series of antibodies that are involved in signal transduction and cancer research. The goal of this collaboration is to combine basic and applied research principles, working with life science researchers to develop better bioreagents that will facilitate biomedical research. These reagents assist in the understanding of cell function as it relates to cancer management. If this product range is of interest to you then please visit our stand and come and speak to James for more information.

< Back to blog list
lorne labs logo


  • Google+
  • LinkedIn